Protein Engineering I - Therapeutics

Monday, November 8, 2010: 8:30 AM
255 A Room (Salt Palace Convention Center)

Description:
This session will focus on protein engineering for therapeutic applications with an emphasis on emerging topics and recent successes. Possible areas of interest include, but are not limited to, (1) advances in protein-based therapeutics, (2) proteins for cellular targeting and imaging, abd (3) proteins involved in disease pathology.


Sponsor:
Bioengineering


Chair:
Jennifer A. Maynard
Email: maynard@che.utexas.edu

Co-Chair:
Bradley C. Bundy
Email: bundy@byu.edu



8:30 AM
(47a) De Novo Computational Design of Nanobodies and Scfvs
Robert J. Pantazes and Costas D. Maranas





9:50 AM


10:00 AM
(47e) Genetically Engineered Alginate Lyase for the Treatment of Bacterial Biofilms
John W. Lamppa, Margaret E. Ackerman, Jennifer Lai, Thomas C. Scanlon and Karl E. Griswold


10:20 AM


10:40 AM
(47g) An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia Coli
J. Manuel Aguilar-Yáñez, Rebecca María Dubois, Gonzalo Ismael Mendoza-Ochoa, Sergio García-Echauri, Roberto Portillo-Lara, David Bulnes-Abundis, Felipe López-Pacheco, Stacey Schultz-Cherry, Stephen White, Charles Russell and Mario M. Alvarez
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division